# Coda Octopus Group, Inc.: Form 10-Q for the period ended Apr 30, 2022

- Company: [Coda Octopus Group, Inc.](/companies/coda.md) (CIK 1334325)
- Form: 10-Q
- Filed: 2022-06-14
- Accepted by EDGAR: Jun 14, 2022, 06:06 ET
- Period: 2022-04-30
- Accession: 0001493152-22-016630
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1334325/000149315222016630/form10-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1334325/000149315222016630/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-04-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-02-01 to 2022-04-30 | $5.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2021-11-01 to 2022-04-30 | $10.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2022-02-01 to 2022-04-30 | $2.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2021-11-01 to 2022-04-30 | $3.6m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2022-02-01 to 2022-04-30 | $3.0m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2021-11-01 to 2022-04-30 | $7.2m | us-gaap:GrossProfit |
| Research and development | 3 months, 2022-02-01 to 2022-04-30 | $517.4k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2021-11-01 to 2022-04-30 | $1.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2022-02-01 to 2022-04-30 | $2.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2021-11-01 to 2022-04-30 | $4.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2022-02-01 to 2022-04-30 | $481.2k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2021-11-01 to 2022-04-30 | $1.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2022-02-01 to 2022-04-30 | −$118.1k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2021-11-01 to 2022-04-30 | $109.3k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-02-01 to 2022-04-30 | $611.3k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2021-11-01 to 2022-04-30 | $1.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-02-01 to 2022-04-30 | $0.05 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2021-11-01 to 2022-04-30 | $0.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-02-01 to 2022-04-30 | $0.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2021-11-01 to 2022-04-30 | $0.17 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-02-01 to 2022-04-30 | 11,405,507 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2021-11-01 to 2022-04-30 | 11,405,263 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2021-11-01 to 2022-04-30 | $4.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2021-11-01 to 2022-04-30 | $1.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-04-30 | $20.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-04-30 | $34.5m | us-gaap:AssetsCurrent |
| Total assets | at 2022-04-30 | $44.9m | us-gaap:Assets |
| Current liabilities | at 2022-04-30 | $3.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-04-30 | $3.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2022-04-30 | $41.5m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1334325/000149315222016630/form10-q.htm

Filed Jun 14, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-016630. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.